200 related articles for article (PubMed ID: 29679071)
1. Determinants of treatment response in first-episode psychosis: an
Jauhar S; Veronese M; Nour MM; Rogdaki M; Hathway P; Turkheimer FE; Stone J; Egerton A; McGuire P; Kapur S; Howes OD
Mol Psychiatry; 2019 Oct; 24(10):1502-1512. PubMed ID: 29679071
[TBL] [Abstract][Full Text] [Related]
2. The Effects of Antipsychotic Treatment on Presynaptic Dopamine Synthesis Capacity in First-Episode Psychosis: A Positron Emission Tomography Study.
Jauhar S; Veronese M; Nour MM; Rogdaki M; Hathway P; Natesan S; Turkheimer F; Stone J; Egerton A; McGuire P; Kapur S; Howes OD
Biol Psychiatry; 2019 Jan; 85(1):79-87. PubMed ID: 30122287
[TBL] [Abstract][Full Text] [Related]
3. A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia.
Jauhar S; Nour MM; Veronese M; Rogdaki M; Bonoldi I; Azis M; Turkheimer F; McGuire P; Young AH; Howes OD
JAMA Psychiatry; 2017 Dec; 74(12):1206-1213. PubMed ID: 29049482
[TBL] [Abstract][Full Text] [Related]
4. The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study.
Jauhar S; McCutcheon R; Borgan F; Veronese M; Nour M; Pepper F; Rogdaki M; Stone J; Egerton A; Turkheimer F; McGuire P; Howes OD
Lancet Psychiatry; 2018 Oct; 5(10):816-823. PubMed ID: 30236864
[TBL] [Abstract][Full Text] [Related]
5. Dopamine synthesis capacity in patients with treatment-resistant schizophrenia.
Demjaha A; Murray RM; McGuire PK; Kapur S; Howes OD
Am J Psychiatry; 2012 Nov; 169(11):1203-10. PubMed ID: 23034655
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic Activity in Antipsychotic-Naïve Patients Assessed With Positron Emission Tomography Before and After Partial Dopamine D
Sigvard AK; Nielsen MØ; Gjedde A; Bojesen KB; Fuglø D; Tangmose K; Kumakura Y; Heltø K; Ebdrup BH; Jensen LT; Rostrup E; Glenthøj BY
Biol Psychiatry; 2022 Jan; 91(2):236-245. PubMed ID: 34743917
[TBL] [Abstract][Full Text] [Related]
7. Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET study.
Rogdaki M; Devroye C; Ciampoli M; Veronese M; Ashok AH; McCutcheon RA; Jauhar S; Bonoldi I; Gudbrandsen M; Daly E; van Amelsvoort T; Van Den Bree M; Owen MJ; Turkheimer F; Papaleo F; Howes OD
Mol Psychiatry; 2023 May; 28(5):1995-2006. PubMed ID: 33981004
[TBL] [Abstract][Full Text] [Related]
8. The relationship between striatal dopamine and anterior cingulate glutamate in first episode psychosis changes with antipsychotic treatment.
Jauhar S; McCutcheon RA; Veronese M; Borgan F; Nour M; Rogdaki M; Pepper F; Stone JM; Egerton A; Vamvakas G; Turkheimer F; McGuire PK; Howes OD
Transl Psychiatry; 2023 May; 13(1):184. PubMed ID: 37253720
[TBL] [Abstract][Full Text] [Related]
9. Dopamine dysregulation in psychotic relapse after antipsychotic discontinuation: an [
Kim S; Shin SH; Santangelo B; Veronese M; Kang SK; Lee JS; Cheon GJ; Lee W; Kwon JS; Howes OD; Kim E
Mol Psychiatry; 2021 Jul; 26(7):3476-3488. PubMed ID: 32929214
[TBL] [Abstract][Full Text] [Related]
10. Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA).
Egerton A; Murphy A; Donocik J; Anton A; Barker GJ; Collier T; Deakin B; Drake R; Eliasson E; Emsley R; Gregory CJ; Griffiths K; Kapur S; Kassoumeri L; Knight L; Lambe EJB; Lawrie SM; Lees J; Lewis S; Lythgoe DJ; Matthews J; McGuire P; McNamee L; Semple S; Shaw AD; Singh KD; Stockton-Powdrell C; Talbot PS; Veronese M; Wagner E; Walters JTR; Williams SR; MacCabe JH; Howes OD
Schizophr Bull; 2021 Mar; 47(2):505-516. PubMed ID: 32910150
[TBL] [Abstract][Full Text] [Related]
11. The relationship between grey matter volume and striatal dopamine function in psychosis: a multimodal
D'Ambrosio E; Jauhar S; Kim S; Veronese M; Rogdaki M; Pepper F; Bonoldi I; Kotoula V; Kempton MJ; Turkheimer F; Kwon JS; Kim E; Howes OD
Mol Psychiatry; 2021 Apr; 26(4):1332-1345. PubMed ID: 31690805
[TBL] [Abstract][Full Text] [Related]
12. Frontostriatal functional connectivity and striatal dopamine synthesis capacity in schizophrenia in terms of antipsychotic responsiveness: an [
Kim S; Jung WH; Howes OD; Veronese M; Turkheimer FE; Lee YS; Lee JS; Kim E; Kwon JS
Psychol Med; 2019 Nov; 49(15):2533-2542. PubMed ID: 30460891
[TBL] [Abstract][Full Text] [Related]
13. Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study.
Howes OD; Bose SK; Turkheimer F; Valli I; Egerton A; Valmaggia LR; Murray RM; McGuire P
Am J Psychiatry; 2011 Dec; 168(12):1311-7. PubMed ID: 21768612
[TBL] [Abstract][Full Text] [Related]
14. Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort.
Egerton A; Chaddock CA; Winton-Brown TT; Bloomfield MA; Bhattacharyya S; Allen P; McGuire PK; Howes OD
Biol Psychiatry; 2013 Jul; 74(2):106-12. PubMed ID: 23312565
[TBL] [Abstract][Full Text] [Related]
15. Striatal dopamine synthesis capacity and its association with negative symptoms upon resolution of positive symptoms in first-episode schizophrenia and delusional disorder.
Wong SMY; Suen YN; Wong CWC; Chan SKW; Hui CLM; Chang WC; Lee EHM; Cheng CPW; Ho GCL; Lo GG; Leung EYL; Yeung PKMA; Chen S; Honer WG; Mak HKF; Sham PC; McKenna PJ; Pomarol-Clotet E; Veronese M; Howes OD; Chen EYH
Psychopharmacology (Berl); 2022 Jul; 239(7):2133-2141. PubMed ID: 35211769
[TBL] [Abstract][Full Text] [Related]
16. Elevated striatal dopamine function linked to prodromal signs of schizophrenia.
Howes OD; Montgomery AJ; Asselin MC; Murray RM; Valli I; Tabraham P; Bramon-Bosch E; Valmaggia L; Johns L; Broome M; McGuire PK; Grasby PM
Arch Gen Psychiatry; 2009 Jan; 66(1):13-20. PubMed ID: 19124684
[TBL] [Abstract][Full Text] [Related]
17. The role of dopamine dysregulation and evidence for the transdiagnostic nature of elevated dopamine synthesis in psychosis: a positron emission tomography (PET) study comparing schizophrenia, delusional disorder, and other psychotic disorders.
Cheng PWC; Chang WC; Lo GG; Chan KWS; Lee HME; Hui LMC; Suen YN; Leung YLE; Au Yeung KMP; Chen S; Mak KFH; Sham PC; Santangelo B; Veronese M; Ho CL; Chen YHE; Howes OD
Neuropsychopharmacology; 2020 Oct; 45(11):1870-1876. PubMed ID: 32612207
[TBL] [Abstract][Full Text] [Related]
18. Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [
Kim E; Howes OD; Veronese M; Beck K; Seo S; Park JW; Lee JS; Lee YS; Kwon JS
Neuropsychopharmacology; 2017 Mar; 42(4):941-950. PubMed ID: 27857125
[TBL] [Abstract][Full Text] [Related]
19. Presynaptic Dopamine Synthesis Capacity in Schizophrenia and Striatal Blood Flow Change During Antipsychotic Treatment and Medication-Free Conditions.
Eisenberg DP; Yankowitz L; Ianni AM; Rubinstein DY; Kohn PD; Hegarty CE; Gregory MD; Apud JA; Berman KF
Neuropsychopharmacology; 2017 Oct; 42(11):2232-2241. PubMed ID: 28387222
[TBL] [Abstract][Full Text] [Related]
20. Reduced striatal dopamine synthesis capacity in patients with schizophrenia during remission of positive symptoms.
Avram M; Brandl F; Cabello J; Leucht C; Scherr M; Mustafa M; Leucht S; Ziegler S; Sorg C
Brain; 2019 Jun; 142(6):1813-1826. PubMed ID: 31135051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
